InFLAMES: Innovation Ecosystem based on the Immune System

Bidragets beskrivning

Normal immune defence system is vital for health. Overactivity of the immune system leads to the development of autoimmune diseases, such as arthritis, multiple sclerosis and juvenile diabetes. Too weak immune responses, on the other hand, predispose us to cancer and severe bacterial and viral infections. Immunomodulation offers a possibility to treat a wide variety of different diseases, but currently only a small fraction of all patients respond favorably. The InFLAMES Flagship aims at identifying novel drug targets using the most modern technological platforms. It participates in the actual drug development in joint efforts with biotech and pharmaceutical companies. It also invents novel diagnostic tools to identify the patients benefitting from personalized therapies. The Flagship will introduce new avenues for the collaboration between the universities and industry, and will enhance entrepreneurship and the translation of new inventions into commercial products.
Visa mer

Startår

2020

Slutår

2023

Beviljade finansiering


945 678 €

Kontaktperson

Patrik Henelius

Rollen i Finlands Akademis konsortium

Partner

Övriga parter i konsortiet

Leader
Åbo universitet (337530)
4 697 185 €

Finansiär

Finlands Akademi

Typ av finansiering

Flaggskepp

Beslutfattare

Suomen akatemian muu päättäjä
12.01.2023

Övriga uppgifter

Finansieringsbeslutets nummer

337531

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Biolääketieteet

Temaområden

Lisätalousarvio IV 2020

Identifierade teman

diabetes, medicine, metabolic diseases